Cover Image

Correction: Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review

Saved in:

Bibliographic Details
Main Authors:	Nikki Bozinoff (Author), Vitor Soares Tardelli (Author), Dafna Sara Rubin-Kahana (Author), Bernard Le Foll (Author)
Format:	Book
Published:	BMC, 2022-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Patterns of use and adverse events reported among persons who regularly inject buprenorphine: a systematic review
by: Nikki Bozinoff, et al.
Published: (2022)

The Insula: A Brain Stimulation Target for the Treatment of Addiction
by: Christine Ibrahim, et al.
Published: (2019)

Correction to: Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France
by: Salim Mezaache, et al.
Published: (2021)

Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France
by: Salim Mezaache, et al.
Published: (2021)

Facilitators of and barriers to buprenorphine initiation in the emergency department: a scoping review
by: Nikki Bozinoff, et al.
Published: (2024)

Pharmacokinetics of buprenorphine in pregnant sheep after intravenous injection
by: Henriikka Hakomäki, et al.
Published: (2021)

Transcriptomic Characterization of the Human Insular Cortex and Claustrum
by: Christine Ibrahim, et al.
Published: (2019)

Depot Buprenorphine Injection In The Management Of Opioid Use Disorder: From Development To Implementation
by: Ling W, et al.
Published: (2019)

Outcomes of patients with schizophrenia who discontinued long‐acting injectable antipsychotic therapy due to adverse events: A chart review
by: Taro Kishi, et al.
Published: (2021)

Unusual Route of Buprenorphine Administration: An Alternative Approach for Bypassing Adverse Drug Reactions
by: Azadeh Nazari, MD, Ph.D, et al.
Published: (2019)

Serious treatment-emergent adverse events in chronic low back pain patients treated with buprenorphine or oral opioids: a retrospective commercial claims analysis
by: Filip Stanicic, et al.
Published: (2024)

Patient-Reported Outcomes, Experiences and Satisfaction with Weekly and Monthly Injectable Prolonged-Release Buprenorphine
by: Parsons G, et al.
Published: (2020)

Depot Buprenorphine Injection in the Management of Opioid Use Disorder: From Development to Implementation [Corrigendum]
by: Ling W, et al.
Published: (2020)

Insula deep rTMS and varenicline for smoking cessation: A randomized control trial study protocol
by: Christine Ibrahim, et al.
Published: (2022)

WHO efforts to promote reporting of adverse events and global learning
by: Itziar Larizgoitia, et al.
Published: (2013)

On P-Injective Modules And Ɣ-Regular Rings
by: Baida S. Abdullah
Published: (2012)

"We want everything in a one-stop shop": acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for Black people who inject drugs
by: Tyler S. Bartholomew, et al.
Published: (2022)

Budget Impact Analysis of the Introduction of Injectable Prolonged-Release Buprenorphine on Opioid Use Disorder Care Resource Requirements
by: Phillips-Jackson H, et al.
Published: (2020)

A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
by: Vorma Helena, et al.
Published: (2008)

Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats
by: Venumadhav Janganati, et al.
Published: (2023)

Influence of buprenorphine replacement therapy
by: Despotović Milena, et al.
Published: (2017)

Adverse childhood experiences and comorbidity in a cohort of people who have injected drugs
by: David W. Sosnowski, et al.
Published: (2022)

An analysis of patterns of distribution of buprenorphine in the United States using ARCOS, Medicaid, and Medicare databases
by: Zhi‐Shan Hsu, et al.
Published: (2023)

Depot buprenorphine as an opioid agonist therapy in New South Wales correctional centres: a costing model
by: R. Ling, et al.
Published: (2022)

Buprenorphine Dosage and Urine Quantitative Buprenorphine, Norbuprenorphine, and Creatinine Levels in an Office-Based Opioid Treatment Program
by: Hiroko Furo, et al.
Published: (2021)

Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation
by: Lori Regenstreif, et al.
Published: (2022)

Recent Methods for Measuring Dopamine D3 receptor Occupancy In Vivo: Importance for Drug Development
by: Bernard eLe Foll, et al.
Published: (2014)

A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes
by: Ingunn O. Lund, et al.
Published: (2013)

A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes
by: Ingunn O. Lund, et al.
Published: (2013)

Transdermal buprenorphine for pain management in children
by: Giorgio Attinà, et al.
Published: (2021)

Advances in the delivery of buprenorphine for opioid dependence
by: Rosenthal RN, et al.
Published: (2017)

Intrathecal buprenorphine for post-op analgesia
by: S Parthasarathy
Published: (2010)

Factors in rural community buprenorphine dispensing
by: Erin G. Major, et al.
Published: (2023)

Buprenorphine Use for Analgesia in Palliative Care
by: Leanne K. Jackson, et al.
Published: (2024)

Variable importance for projection (VIP) scores for analyzing the contribution of risk factors in severe adverse events to Xiyanping injection
by: Rui Zheng, et al.
Published: (2023)

Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
by: Mark K. Greenwald, et al.
Published: (2023)

Peripartum and Postpartum Analgesia and Pain in Women Prescribed Buprenorphine for Opioid Use Disorder Who Deliver by Cesarean Section
by: Alane B O'Connor, et al.
Published: (2022)

Comment on "A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes"
by: Robert G. Newman M.D., M.P.H, et al.
Published: (2013)

Comment on "A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence During Pregnancy: Maternal and Neonatal Outcomes"
by: Robert G. Newman, et al.
Published: (2013)

Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
by: Ming-Tao Wen, et al.
Published: (2024)